Evidence map›Paper›PMID 32731639›Full record

ReviewInternational journal of molecular sciences2020

Microvesicles in Cancer: Small Size, Large Potential.

Kerstin Menck, Suganja Sivaloganathan, Annalen Bleckmann, Claudia Binder

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Exosomal ncRNAs in reproductive cancers†.Biology of reproduction · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kerstin MenckDepartment of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, 48149 Münster, Germany.ORCID 0000-0002-8188-0163
Suganja SivaloganathanDepartment of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, 48149 Münster, Germany.
Annalen BleckmannDepartment of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, 48149 Münster, Germany.
Claudia BinderDepartment of Hematology/Medical Oncology, University Medical Center Göttingen, 37075 Göttingen, Germany.

Funding

Bundesministerium für Bildung und Forschung 031L0024Deutsche Forschungsgemeinschaft 424252458Gerdes-Stiftung, Innovative Medizinische Forschung ME 1 2 19 14
6 · The paper itself

Abstract

Extracellular vesicles (EV) are secreted by all cell types in a tumor and its microenvironment (TME), playing an essential role in intercellular communication and the establishment of a TME favorable for tumor invasion and metastasis. They encompass a variety of vesicle populations, among them the well-known endosomal-derived small exosomes (Exo), but also larger vesicles (diameter > 100 nm) that are shed directly from the plasma membrane, the so-called microvesicles (MV). Increasing evidence suggests that MV, although biologically different, share the tumor-promoting features of Exo in the TME. Due to their larger size, they can be readily harvested from patients' blood and characterized by routine methods such as conventional flow cytometry, exploiting the plethora of molecules expressed on their surface. In this review, we summarize the current knowledge about the biology and the composition of MV, as well as their role within the TME. We highlight not only the challenges and potential of MV as novel biomarkers for cancer, but also discuss their possible use for therapeutic intervention.

Indexed as

Cell CommunicationTumor MicroenvironmentBiomarkers, TumorCell-Derived MicroparticlesExosomesHumansNeoplasmsBiomarkers, Tumorbiomarkercancermicrovesiclestherapytumor microenvironment

Identifiers

PMID32731639
PMCPMC7432491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.